ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 402717 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 402717; 2) Community: the network communities that were significantly associated with the response to NSC 402717; 3) Molecule: the relationships between components within communities and NSC 402717; 4) MDR: the compounds that were significantly associated with the NSC 402717.

NSC Compound Enrichment Correlation
NSC 127128 Null 0.0339770934764516 0.015066467
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 0.0339770934764516 0.23365313
NSC 136468 Null 0.0339770934764516 0.14215071
NSC 254677 Phomazarin 0.0339770934764516 -0.19304161
NSC 290193 CYCLOSPORIN A 0.0339770934764516 0.27758427
NSC 333856 NSC 329083 0.0339770934764516 0.016623363
NSC 106557 5.alpha.,25D-Spirostan-3.beta.-ol glycoside 0.035202825328704 -0.055768648
NSC 126668 Null 0.035202825328704 0.29225718
NSC 329515 Kijanimicin sodium salt 0.035202825328704 0.16869306
NSC 405159 2,5-Cyclohexadiene-.delta.1,.alpha.-acetonitrile, 4-oxo-.alpha.-phenyl-, oxime 0.0352028253287042 0.27892049
Total:89  Current:65    [First] [Prev] [Next] [Last]